These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 508675)

  • 1. Effect of lisuride on inhibition of lactation and serum prolactin.
    De Cecco L; Venturini PL; Ragni N; Rossato P; Maganza C; Gaggero G; Horowski R
    Br J Obstet Gynaecol; 1979 Nov; 86(11):905-8. PubMed ID: 508675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of lactation with lisuride.
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Gynecol Obstet Invest; 1979; 10(2-3):95-105. PubMed ID: 535777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lactation inhibition with various dosages of lisuride--prolactin secretion and effectiveness].
    Strahl HJ; Göretzlehner G; Strahl S; Kunkel S
    Zentralbl Gynakol; 1985; 107(5):300-3. PubMed ID: 4039514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic arrest of lactation. Comparison of Deprenon, lisuride, terguride and mestranol].
    Vido I; Cepický P
    Cesk Gynekol; 1989 Nov; 54(9):654-61. PubMed ID: 2624954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactation-inhibiting and prolactin-lowering effect of lisuride and transdihydrolisuride. A comparative study.
    Vĕtr M; Konecný V
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():295-300. PubMed ID: 2977904
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine and clinical results in administering lisuride for inhibiting lactation.
    Zanagnolo VL; Pollini F; Falsetti L; Gastaldi A
    Acta Eur Fertil; 1987; 18(1):21-4. PubMed ID: 3115024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-lowering effect of low doses of lisuride in man.
    Horowski R; Wendt H; Gräf KJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):234-40. PubMed ID: 415471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of puerperal lactation by terguride. A double-blind study.
    Venturini PL; Horowski R; Fasce V; Valenzano M; Ferreri C; Badino G; Rainer E; Scholz A; De Cecco L
    Gynecol Obstet Invest; 1988; 26(1):33-8. PubMed ID: 3049266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women.
    Venturini PL; Horowski R; Valenzano M; Costantini S; Fasce V; Gorlero F; Rainer E; De Cecco L
    Eur J Clin Pharmacol; 1986; 30(2):195-7. PubMed ID: 3709645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG; Kato K; De Moll H
    Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of lisuridhydrogen maleate on prolactin secretion in puerperium].
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Arch Gynecol; 1979 Jul; 228(1-4):585-6. PubMed ID: 485487
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of lactation with lisuride. CLinical evaluation].
    Sereno Coló JA; Navarrete Horta MT
    Ginecol Obstet Mex; 1994 Jan; 62():31-4. PubMed ID: 8168721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses.
    De Cecco L; Foglia G; Ragni N; Rossato P; Venturini PL
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):491-8. PubMed ID: 106990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lactation with Terguride.
    Vĕtr M; Krejcí I
    Acta Univ Palacki Olomuc Fac Med; 1988; 119():347-52. PubMed ID: 2977495
    [No Abstract]   [Full Text] [Related]  

  • 18. Puerperal lactation inhibition with a novel 8 alpha-aminoergoline (CU 32-085).
    Kvist Poulsen H; Rasmussen P; Riber Petersen M; Møller Pedersen S
    Gynecol Obstet Invest; 1984; 17(3):139-44. PubMed ID: 6706248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative, bromerguride.
    Krause W; Sauerbrey N; Gräf KJ
    Eur J Clin Pharmacol; 1986; 31(2):165-8. PubMed ID: 3803415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisuride, a dopamine agonist, inhibits DNA synthesis in the pituitary gland.
    Burdman JA; Calabrese MT; Harcus CT; MacLeod RM
    Neuroendocrinology; 1982 Oct; 35(4):282-6. PubMed ID: 7145022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.